Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Fentanyl Sandoz
Active Ingredient: Fentanyl 2.1mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Hexal AG, Holzkirchen, Germany
   
Product: Fentanyl Sandoz
Active Ingredient: Fentanyl 4.2mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Hexal AG, Holzkirchen, Germany
   
Product: Fentanyl Sandoz
Active Ingredient: Fentanyl 6.3mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Hexal AG, Holzkirchen, Germany
   
Product: Fentanyl Sandoz
Active Ingredient: Fentanyl 8.4mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Hexal AG, Holzkirchen, Germany
   
Product: Fentanyl Sandoz
Active Ingredient: Fentanyl 12.6mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Hexal AG, Holzkirchen, Germany
   
Product: Fentanyl Sandoz
Active Ingredient: Fentanyl 16.8mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Hexal AG, Holzkirchen, Germany


Dated this 16th day of May 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).